MANAMA: The National Health Regulatory Authority (NHRA) has approved Regn-Cov2 for emergency use to treat Covid-19 cases with mild to moderate symptoms. Regn-Cov2 developed by Regeneron and Roche, contains a combination of Casirivimab and Imdevimab (monoclonal antibodies) and is...
The platform, accessible through the authority's website using secure UAE Pass log in, was unveiled on January 20 during a press conference
A new platform...
